MENU
AIM
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
AIM ImmunoTech (AIM) Ownership - Who owns AIM ImmunoTech?
AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies... Show more
Profile
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.07M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
2.52M
Revenue
N/A
Risk (Beta)
1.66
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.24 USD as % of share price
Fundamentals
AIM
Capitalization
7.07M
P/E Ratio
N/A
Risk (Beta)
1.66
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
2.52M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.24%
Revenue
N/A
ROE
N/A
Book Value
-3.86M
P/B Ratio
2.89
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
72K
Current Ratio
0.26
Current Revenue Per Employee
695.65
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
37.50
Revenue To Assets
N/A
Shares Held By Institutions
977K
Shares Outstanding - Current
764K
Total Liabilities
10.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-53.283
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com